At the conference there were presentations and case studies from more than 1,000 speakers and 385 exhibiting companies including Maximax International Inc.

 

Maximax International Inc. was represented at DIA’s Annual Conferences by four members:

• Jacquelyn Arzooyan, Senior Manager

• Ms. Rayonne Caesar-Chavannes, MBA/HCM, BSc, Director, North America

• Stanley A. Edlavitch, PhD, MA, Executive Director, Scientific Affairs

• Marc Rich, MS, MBA Secretary, Board of Directors

 

The DIA Annual Meeting has chronicled events of profound impact to the development of medicines; has offered a forum to innovators, critics, thought leaders, regulators, and students; has attracted and  nurtured an ever-expanding multinational constituency; and has become the must-attend event of the year.

 

DIA meetings offer the opportunity to meet face to face with qualified prospects involved in the clinical and regulatory development of pharmaceuticals.The DIA Annual Meeting is one of the largest venues in the industry for exhibitors.

 

Every year DIA holds more than 100 meetings, workshops and conferences around the world, offering opportunities for exhibiting. Attendee numbers at DIA events range from 50 - 6,000. Annual conferences with exhibit halls include the Annual Meeting, the Annual EuroMeeting, the Electronic Document Management Conference and the Clinical Data Management Conference.